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Abstract: Recent data indicates an increasing rate of vancomycin resistance in clinical enterococcal isolates worldwide. 
The nosocomial enterococci are likely to harbor virulence elements that increase their ability to colonize hospitalized 
patients. The aim of this study was to characterize virulence determinants in vancomycin-resistant enterococci (VRE) 
obtained from various clinical sources. 
During the years 2008 to 2010, a total of 48 VRE isolates were obtained from three University teaching hospitals in 
Northwest, Iran. Initially, phenotypic speciation was done and minimum inhibitory concentrations (MICs) of vancomycin 
were determined by agar dilution method and E-test. Then, species identification and resistance genotypes along with 
detection of virulence genes (asa1, esp, gelE, ace and cpd) of the isolates were performed by multiplex PCR.  
Thirty eight isolates were identified as vancomycin-resistant Enterococcus faecium (VREfm) and ten as E. faecalis 
(VREfs). Irrespective of the species, vanA gene (89.58%) was dominant and three phenotypically vancomycin susceptible 
E. faecium isolates carried the vanB gene. Among virulence genes investigated, the esp was found in 27(71%) VREfm 
strains, but did not in any VREfs. Other virulence determinants were highly detected in VREfs strains. Our data indicate a 
high prevalence of E. faecium harboring vancomycin resistance with vanA genotype and the two VRE species displayed 
different virulence genes. 
Keywords: Enterococcus faecalis, Enterococcus faecium, Vancomycin resistance, Virulence gene.  
INTRODUCTION 
  Enterococci are Gram-positive intestinal commensals   
of humans and other animals, in addition to be an isolate   
from environmental sources. During the past decades an 
enhancement in the prevalence of enterococal infections such 
as bacteremia and urinary tract infections along with 
emergence of multi antimicrobial resistance, particularly 
VRE has been reported worldwide [1, 2]. 
  Among vancomycin-resistance phenotypes in enterococci, 
VanA and VanB possess highest clinical importance. Strains 
resistant to vancomycin and teicoplanin were assigned to 
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VanA phenotype while, those susceptible to teicoplanin but 
resistant to vancomycin were considered as the VanB 
phenotype [2]. The vanA and vanB gene clusters contain nine 
different genes for a two-component regulatory system 
(vanR  and  vanS), three resistance genes (vanH, encoding 
dehydrogenase;  vanA or vanB, encoding ligase; vanX, 
encoding DD-dipeptidase); an accessory gene (vanY); and 
the  vanZ  gene, which is present in the vanA  gene cluster 
whereas, the vanW gene is found only in the vanB operon. 
VanA is carried on Tn1546  whilst, VanB on transposons 
Tn1547 and Tn1549, which may be found on plasmids or 
inserted on the chromosome [3]. 
  Despite the fact that E. faecalis has been observed as the 
predominant species in clinical infections, an increase in the 
prevalence of E. faecium has been seen recently [4]. This 
shift is likely to be explained in part by the emergence of 
vancomycin resistant enterococci (VRE) and E. faecium 
being the dominant detectable species among them [5]. Incidence of Virulence Genes among VRE Isolates  The Open Microbiology Journal, 2012, Volume 6    35 
Unfortunately, little is known about the pathogenic 
mechanisms or virulence factors of this microorganism [6]. 
Enterococcal infections may occur via the ability to persist 
on harsh environments due to their intrinsic properties and 
even these conditions may contribute largely to emergence of 
this organism as a nosocomial pathogen [7, 8]. The process 
of invasion is usually facilitated by damage to host tissues 
and the presence of bacterial virulence factors such as 
adhesins along with antibiotic resistance that gradually assist 
in advancement and furtive survival in newly infected place. 
At the next, enterococci utilize several virulence factors for 
adherence and colonization in the infection site by formation 
of cell aggregates such as biofilms [5, 9]. At the end, 
interactions between host and enterococci leads to the 
clinical manifestation of infection in target vital tissues [5].  
  By consideration of the fact that the presence of putative 
virulence determinants among clinical isolates may promote 
emergence of infections and persistence of enterococci in 
nosocomial locations causes an increase in antibiotic 
resistance and act as facilities for emerging infections [10, 
11], this study was designed to survey distribution of 
virulence genes including asa1(aggregation substance), esp 
(Enterococcal surface protein), gelE (gelatinase), ace 
(collagen adhesion) and cpd (sex pheromones determinant) 
in clinical isolates of vancomycin resistant E. faecalis and E. 
faecium at molecular level. To our knowledge, this is the 
first report from the Northwest of Iran. 
MATERIALS AND METHODOLOGY 
VRE Isolates and Susceptibility Tests 
  Thirty-eight VREfm and 10 VREfs isolates, obtained 
from different clinical specimens submitted in three 
University teaching hospitals of Tabriz (Imam Reza and Sina 
Hospitals) and Orumieh (Imam Khomeini Hospital), Iran, 
between 2008 and 2010. The origins of isolates were as 
follows: urine 35 (72.91%), blood 5 (10.41%), wound 
3(6.25%), body fluids 4(8.33%) and intravenous catheter 
1(2.08%). Initially, these isolates were identified to the 
species level by conventional methods described previously 
[12] and then, multiplex PCR was used to detect vancomycin 
resistant  vanA and vanB genes and also to confirm 
phenotypic speciation by targeting D-alanine– D-alanine 
ligases specific for E. faecalis (ddlE. faecalis) and E. faecium 
(ddlE. faecium) as developed by Kariyama et al., [13]. E. 
faecalis E206 (vanA
+) and E. faecium E2781 (vanB
+) (kindly 
provided by Dr. Eimaneini) was used as control strains.  
  For all isolates, MICs of vancomycin were determined by 
agar dilution method and E-test (BioMerieux, SA) according 
to the CLSI’s (2006) guidelines [14] and manufacturer’s 
recommendations, respectively. E. faecalis ATCC 29212 
was used as a quality control strain on every occasion of 
susceptibility testing. 
Detection of Virulence Genes by PCR 
  DNA extraction was performed by boiling method as 
described previously [15] and then by commercial kit 
(DNG
TM-Plus, CinnaGen, Iran). Multiplex PCR was 
performed on all enterococcal isolates for the detection of 
virulence determinants with specific primers for each gene 
(Table  1) with some modification on Vankerckhoven’s 
protocol [16]. Briefly, first 25l master mix containing   
2.5l of bacterial suspension, 15pM of each primers for asa1 
and gelE and 30 pM for esp, 1X PCR buffer, 2.0 mM MgCl2, 
0.2 mM each deoxynucleotide triphosphate (dATP, dCTP, 
Table 1.  Primers used in this Study 
Genes  Sequence (5' to 3')  Size(bp)  References 
asa1 
F1: GCACGCTATTACGAACTATGA 
R1:  TAAGAAAGAACATCACCACGA 
375 [15] 
gelE 
F2:  TATGACAATGCTTTTTGGGAT 
R2:  AGATGCACCCGAAATAATATA 
213 [15] 
esp 
F7:  AGATTTCATCTTTGATTCTTGG 
R7:  AATTGATTCTTTAGCATCTGG 
510 [15] 
cpd 
F8: TGGTGGGTTATTTTTCAATTC 
R8: TACGGCTCTGGCTTACTA 
782 [29] 
ace 
F9: GGAATGACCGAGAACGATGGC 
R9: GCTTGATGTTGGCCTGCTTCCG 
616 [14] 
vanA 
F14-CATGAATAGAATAAAAGTTGCAATA 
R14-CCCCTTTAACGCTAATACGATCAA 
1030 [12] 
vanB 
F15-GTGACAAACCGGAGGCGAGGA 
R15-CCGCCATCCTCCTGCAAAAAA 
433  [12] 
E. faecalis 
F16-ATCAAGTACAGTTAGTCTTTATTAG 
R16-ACGATTCAAAGCTAACTGAATCAGT 
941 [12] 
E. faecium 
F17-TTGAGGCAGACCAGATTGACG 
R17-TATGACAGCGACTCCGATTCC 
658 [12] 36    The Open Microbiology Journal, 2012, Volume 6  Sharifi et al. 
dGTP, and dTTP) and 2.5 U of Taq  DNA polymerase 
(CinnaGen, Iran). The second PCR mixture contained 10 pM 
of each primer for cpd and 4pM for ace, 1.5 mM MgCl2 and 
additional rest of reagents mentioned in first master mix. 
Reactions for both mixtures were done on a thermal cycler 
(ASTEC-Japan) with an initial denaturation at 95°C for 10 
min, 30 cycles of amplification (denaturation at 94°C for 1 
min, annealing at 56°C for 1 min, and extension at 72°C for 
1 min), and a final extension at 72°C for 10 min.  
  Amplicons were analyzed on a 1.5% agarose gel and a 
100-bp DNA ladder was used as the molecular size marker. 
The gels were stained with ethidium bromide and photo- 
graphed under UV light. Each PCR assay was accompanied 
with a negative control, containing all of the reagents 
without template DNA. 
Statistical Analysis 
  Data were analyzed statistically using chi-square test and 
difference was considered significant at p<0.05 by SPSS 
software (version 18). 
RESULTS 
  Most of VREs were isolated from intensive care units 
(ICUs) [16(33.3%)], nephrology [10(20.8%)] and internal 
[8(16.7%)] wards. Among VRE strains, thirty- five E. 
faecium  harboured  vanA gene and all of them revealed 
MICs 256 g/ml, except one (MIC=8g/ml). Five vanA 
positive isolates did not show any studied virulence 
determinants. On the other hand, 3 E. faecium isolates 
carried vanB gene with MICs 4 g/ml and also, they were 
negative for all virulence determinants tested. However, 
VREfm isolates were found with the esp gene (71.05%).  
 All  E. faecalis showed MICs  256 g/ml and 8 isolates 
carried vanA gene while, in the two strains, neither vanA nor 
vanB gene were detected.  
 In  comparison  to  E. faecium, vancomycin resistant E. 
faecalis strains were furnished with diverse combinations of 
virulence genes include: 4 strains presenting asa1, gelE, ace 
and cpd; 4 strains with asa1, gelE and cpd; 1 strain showed 
gelE, ace and cpd and another one displayed gelE and cpd. 
Among virulence genes studied, concomitant occurrence of 
gelE and cpd in all E. faecalis isolates was significant 
(p0.001). Distribution of virulence genes among vancomycin 
resistant E. faecalis and E. faecium are shown in Table 2.  
Table 2.  Distribution of Virulence Genes among Vancomycin 
Resistant E. faecalis and E. faecium Isolates 
Vancomycin  Resistant   Virulence 
Genes 
E. faecalis                      E. faecium  
(N=10)                           (N=38) 
Total 
(N=48) 
gelE 
asa1 
cpd 
ace 
esp 
10 (100)                          3(7.89) 
8 (80)                              3(7.89) 
10(100)                           1(2.63) 
5(50)                               1(2.63) 
0(0)                                  27(71.05) 
13(27.08) 
11(22.91) 
11(22.91) 
6(12.5) 
27(56.25) 
DISCUSSION 
  This study investigated prevalence of virulence factors in 
vancomycin resistant enterococci. The majority of VREs 
were E. faecium (38 out of 48 VREs). Similar enhancement 
in the prevalence of VRE, especially E. faecium has been 
noticed earlier in several studies from different countries 
[17-19]. This increase has been attributed mainly to the 
occurrence and spread of vanA and vanB positive VRE, 
which exhibited some virulence factors such as Esp (esp), 
cytolysin (cyl), hyaluronidase (hyl) [10]. In comparison 
among various sources of Enterococci, the same as clinical 
samples, farm animals, water and food products, isolates 
from clinical specimens have been attributed to have the 
highest virulence factors [20, 21]. In this study, E. faecalis 
and E. faecium strains show significantly different patterns 
in the incidence of virulence determinants. Similar to study 
of Eaton et al., (2001), in our study, all E. faecalis strains 
harbored multiple virulence determinants. 
  The aggregation substance is a pheromone-inducible 
surface protein encoded by asa1 gene involved in adherence 
to eukaryotic cell [22], which may increase the hydro- 
phobicity of the enterococcal cell surface that may delay or 
prevent fusion with lysosomal vesicles [23], cell aggregation 
and conjugation [24]. Various reports are available for the 
prevalence of asa1 in enterococcal isolates obtained from 
different sources. In this study 8 out of 10 E. faecalis 
harbored asa1 gene and majority (62.5%) of them were being 
isolated from urine specimen. Waar et al., (2002) reported 
high prevalence of asa1 in E. faecalis isolates from liver 
transplant and septicemic patients and assumed that asa1 
might be associated with infection [25]. Baldassarri et al., 
[26] indicated presence of this gene in seven out of 11 E. 
faecalis from endocarditis, with only one strain being vanA 
positive. The present study also revealed this gene in 3 (7.89 
%) VREfm isolates from UTI, whereas other studies did not 
find asa1 in E. faecium [16, 27, 28]. A much higher incidence 
(13%) has been reported by Elsner et al., [29] in clinical  
E. faecium isolated from blood culture. A study on food   
and medical isolates of enterococci showed the asa1 gene 
was always associated with the presence of pheromone 
determinants (cpd, cob, ccf and cad ) and only detected in  
E. faecalis [30]. Abriouel et al., (2008) reported high 
prevalence of cpd (89.7%) determinant in comparison of 
aggregation substance (58.97%) in clinical E. faecalis [28]. 
Similarly, we found the cpd gene in all VREfs, of them 80% 
were also asa1 positive (p0.001). Meanwhile, we could 
find  cpd in one VREfm, suggests that it is probably not 
associated with virulence in this species. The presence of sex 
pheromone determinant in E. faecium was reported earlier 
[31]. 
  Gelatinase encoded by gelE is an extracellular 
metalloendopeptidase that hydrolyzes gelatin, collagen, 
hemoglobin, and other bioactive compounds [32]. Sabia   
et al., (2008) reported gelE gene in 19 (70%) out of 27 VRE 
strains; all E. faecalis and 5 out of 7 E. faecium carried the 
gelE [33]. In accordance, we detected gelE gene in all VREfs 
and 7.9% of VREfm. In fact, among virulence genes 
investigated, concomitant occurrence of gelE and cpd in  
E. faecalis isolates was found significant (p0.001). In 
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faecium isolates [34] while, other researchers reported 
different incidence for mentioned gene in clinical isolates 
[11, 27]. Silent form of this gene was reported in E. faecium 
isolates [30, 35].  
 The  ace gene, which codes for a putative protein with 
characteristics similar to a collagen-binding protein of 
Staphylococcus aureus [36] has been identified more 
frequently in E. faecalis isolates [27, 37]. Abriouel et al., 
(2008) reported higher incidence of ace gene (>80%) in 
clinical isolates in comparison to much lower incidence   
or even absence in isolates obtained from vegetable foods, 
water and soil [28]. The present study revealed the ace  
gene in 50% of E. faecalis and only in one E. faecium. All 
ace positive isolates obtained from urine (UTI) and isolates 
from other sources were negative for this gene. Lebreton   
et al., (2009) suggested that Ace may be a valuable drug 
target against human UTI. Low incidence or absence of   
the ace in clinical E. faecium have been reported in some 
studies [11, 27] but it is unlikely to contribute significantly 
to virulence.  
  Esp protein encoded by esp gene assumed to play a role 
in the primary surface attachment, contributing to 
colonization and persistence on urinary tract and biofilm 
formation [38, 39]. The esp is one of the disputed virulence 
elements that found on a pathogenicity island of both E. 
faecalis and E. faecium [40, 41].  
  Although, an earlier study demonstrated esp gene only in 
E. faecalis isolates [42] and other available data indicated 
that the esp gene was common in E. faecalis [15] however, a 
study on the food and medical isolates depicted an increasing 
incidence of esp  in  clinical E. faecium isolates than E. 
faecalis [30] and an European investigation proposed, 
proposed only this gene for virulence among this species 
[16]. Camargo et al., (2006) demonstrated that esp (56%) 
was restricted to VREfm and not found in vancomycin 
sensitive E. faecium [43]. Vankerckhoven et al., [16] surveyed 
virulence genes in European hospitals and found higher 
incidence of esp  in the clinical VREfm isolates. In 
accordance with these investigations, in our study esp was 
the most common gene in VREfm (71.05%) but not detected 
in VREfs. Moreover, earlier Van Wamel et al., (2007) 
demonstrated that Esp expression on the surface of E. 
faecium; dependent to growth condition, to vary consistently 
among strains and is quantitatively correlated with initial 
adherence and biofilm formation [44].  
  In the present study, three E. faecium isolates with   
vanB genotype were susceptible to vancomycin (MIC< 4 
g/ml) and did not carry any of examined virulence 
determinants. A research conducted on Australian patients 
with haematological disorders showed high incidence of esp 
gene in vancomycin resistant E. faecium (vanB positive), but 
all were negative for asa1 and gelE [45]. 
CONCLUSION 
  Our data indicate a high prevalence of E. faecium 
harboring vancomycin resistance with vanA genotype. In 
addition, finding of 3 E. faecium with vanB genotype,   
but sensitive to vancomycin, suggest application of   
both phenotypic and genotypic methods for screening   
VRE strains since using them in single may lead to 
misidentification.  
  VREfs possessed four distinctive patterns of virulence 
factors and the gelE gene was always associated with the 
presence of pheromone determinant (cpd) and these 
combinations may associate with increased virulence. 
Interestingly, esp was not found in any of VREfs strains.  
  On the other hand, the esp was the dominant determinant 
among  E. faecium strains. Finding of esp gene in high 
incidence among E. faecium, but not in E. faecalis, may 
indicate the role of this gene in high prevalence of VREfm in 
hospitals environments. Although the gelE, cpd, asa1and ace 
genes were found in less frequencies, but there is a trend of 
increasing levels of virulence genes other than esp among E. 
faecium strains.  
  Meanwhile, in 8 of VREfm (3 vanB
+ and five vanA
+) 
none of these genes was present, it was concluded that other 
genes may be also important in the pathogensis of VRE 
isolates. 
  However, further investigation is required to evaluate the 
association of these virulent determinants with occurrence of 
an infection by VREs in more number of isolates.  
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